Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FrontlineODP Spray Dried Plasma
- Development stage
- Unknown
- Lead developer
- Velico
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Intravenous
01
Overview
FrontlineODP Spray Dried Plasma is an investigational, shelf-stable, human plasma-derived biologic developed by Velico Medical for the treatment of traumatic hemorrhage and hemorrhagic shock. Produced from conventional donor plasma using the FrontlineODP System, the product is designed for use in pre-hospital settings, emergency medical services, and military applications where conventional frozen plasma is unavailable or impractical. It is shelf-stable for up to 24 months at room temperature and can be reconstituted in under three minutes with sterile water for injection. The development program is supported by the Biomedical Advanced Research and Development Authority (BARDA) to address the critical need for immediate plasma availability in austere or rural environments to manage coagulopathy and improve survival in trauma patients.
- Brand names
- FrontlineODP
- Other names
- FrontlineODP Spray Dried PlasmaVelico Spray Dried PlasmaOn Demand Plasma
02
Targets
F (Coagulation factors)
Beyond the preview
Go deeper on FrontlineODP Spray Dried Plasma.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FrontlineODP Spray Dried Plasma.